Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Skin disease prevalence study in schoolchildren in rural Côte d'Ivoire: Implications for integration of neglected skin diseases (skin NTDs).
Yotsu RR, Kouadio K, Vagamon B, N'guessan K, Akpa AJ, Yao A, Aké J, Abbet Abbet R, Tchamba Agbor Agbor B, Bedimo R, Ishii N, Fuller LC, Hay R, Mitjà O, Drechsler H, Asiedu K. Yotsu RR, et al. Among authors: ake j. PLoS Negl Trop Dis. 2018 May 17;12(5):e0006489. doi: 10.1371/journal.pntd.0006489. eCollection 2018 May. PLoS Negl Trop Dis. 2018. PMID: 29771976 Free PMC article.
Buruli ulcer in Liberia, 2012.
Kollie K, Amoako YA, Ake J, Mulbah T, Zaizay F, Abass M, Lehman L, Paintsil A, Sarfo F, Lugala C, Tiendrebeogo A, Phillips R, Asiedu K. Kollie K, et al. Among authors: ake j. Emerg Infect Dis. 2014 Mar;20(3):494-6. doi: 10.3201/eid2003.130708. Emerg Infect Dis. 2014. PMID: 24565610 Free PMC article. No abstract available.
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding.
Bai H, Lewitus E, Li Y, Thomas PV, Zemil M, Merbah M, Peterson CE, Thuraisamy T, Rees PA, Hajduczki A, Dussupt V, Slike B, Mendez-Rivera L, Schmid A, Kavusak E, Rao M, Smith G, Frey J, Sims A, Wieczorek L, Polonis V, Krebs SJ, Ake JA, Vasan S, Bolton DL, Joyce MG, Townsley S, Rolland M. Bai H, et al. Among authors: ake ja. Nat Commun. 2024 May 9;15(1):3924. doi: 10.1038/s41467-024-48139-x. Nat Commun. 2024. PMID: 38724518 Free PMC article.
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: a national study.
Bakri FG, Mukattash HH, Esmeiran H, Schluck G, Storme CK, Broach E, Mebrahtu T, Alhawarat M, Valencia-Ruiz A, M'Hamdi O, Malia JA, Hassen Z, Shafei MMS, Alkhatib AY, Gazo M, Jaradat SA, Gomez Y, McGeehon S, McCauley MD, Moreland SC, Darden JM, Amare M, Crowell TA, Vasan S, Michael NL, Ake JA, Modjarrad K, Scott PT, Peel SA, Hakre S; RV505 study group. Bakri FG, et al. Among authors: ake ja. Int J Infect Dis. 2024 Apr 30:107079. doi: 10.1016/j.ijid.2024.107079. Online ahead of print. Int J Infect Dis. 2024. PMID: 38697607 Free article.
Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
Mwesigwa B, Sawe F, Oyieko J, Mwakisisile J, Viegas E, Akintunde GA, Kosgei J, Kokogho A, Ntinginya N, Jani I, Shukarev G, Hooper JW, Kwilas SA, Ward LA, Rusnak J, Bounds C, Overman R, Badorrek CS, Eller LA, Eller MA, Polyak CS, Moodley A, Tran CL, Costanzo MC, Leggat DJ, Paquin-Proulx D, Naluyima P, Nkafu Anumendem D, Gaddah A, Luhn K, Hendriks J, McLean C, Douoguih M, Kibuuka H, Robb ML, Robinson C, Ake JA. Mwesigwa B, et al. Among authors: ake ja. Clin Infect Dis. 2024 Apr 24:ciae215. doi: 10.1093/cid/ciae215. Online ahead of print. Clin Infect Dis. 2024. PMID: 38657084
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
Happe M, Hofstetter AR, Wang J, Yamshchikov GV, Holman LA, Novik L, Strom L, Kiweewa F, Wakabi S, Millard M, Kelley CF, Kabbani S, Edupuganti S, Beck A, Kaltovich F, Murray T, Tsukerman S, Carr D, Ashman C, Stanley DA, Ploquin A, Bailer RT, Schwartz R, Cham F, Tindikahwa A, Hu Z, Gordon IJ, Rouphael N, Houser KV, Coates EE, Graham BS, Koup RA, Mascola JR, Sullivan NJ, Robb ML, Ake JA, Lyke KE, Mulligan MJ, Ledgerwood JE, Kibuuka H; VRC 208 and RV 422 study team. Happe M, et al. Among authors: ake ja. NPJ Vaccines. 2024 Mar 29;9(1):67. doi: 10.1038/s41541-024-00833-z. NPJ Vaccines. 2024. PMID: 38553525 Free PMC article.
Cumulative exposure to depressive symptoms and all-cause mortality among adults living with HIV in Kenya, Nigeria, Tanzania, and Uganda.
Kemp CG, Pence BW, Velloza J, Concepcion T, Moitra M, Iroezindu M, Bahemana E, Kibuuka H, Semwogerere M, Owuoth J, Maswai J, Langat R, Esber AL, Dear NF, Parikh A, Crowell TA, Ake JA, Polyak CS, Collins PY; AFRICOS Study Group. Kemp CG, et al. Among authors: ake ja. AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003891. Online ahead of print. AIDS. 2024. PMID: 38507586
Advanced HIV disease in East Africa and Nigeria, in The African Cohort Study.
Oboho IK, Esber AL, Dear N, Paulin HN, Iroezindu M, Bahemana E, Kibuuka H, Owuoth J, Maswai J, Shah N, Crowell TA, Ake JA, Polyak CS; AFRICOS Study Group. Oboho IK, et al. Among authors: ake ja. J Acquir Immune Defic Syndr. 2024 May 1;96(1):51-60. doi: 10.1097/QAI.0000000000003392. Epub 2024 Apr 10. J Acquir Immune Defic Syndr. 2024. PMID: 38427929 Free PMC article.
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.
N'guessan KF, Machmach K, Swafford I, Costanzo MC, Wieczorek L, Kim D, Akapirat S, Polonis VR, Pitisuttithum P, Nitayaphan S, Gurunathan S, Sinangil F, Chariyalertsak S, Ake JA, O'connell RJ, Vasan S, Paquin-Proulx D. N'guessan KF, et al. Among authors: ake ja. Front Immunol. 2024 Feb 13;15:1339727. doi: 10.3389/fimmu.2024.1339727. eCollection 2024. Front Immunol. 2024. PMID: 38420129 Free PMC article. Clinical Trial.
162 results